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Abstract
Improved methods for imaging and assessment of vascular defects are needed for directing
treatment of cardiovascular pathologies. In this paper, we employ magnetomotive optical
coherence tomography (MMOCT) as a platform both to detect and to measure the elasticity of
blood clots. Detection is enabled through the use of rehydrated, lyophilized platelets loaded with
superparamagnetic iron oxides (SPIO-RL platelets) that are functional infusion agents that adhere
to sites of vascular endothelial damage. Evidence suggests that the sensitivity for detection is
improved over threefold by magnetic interactions between SPIOs inside RL platelets. Using the
same MMOCT system, we show how elastometry of simulated clots, using resonant acoustic
spectroscopy, is correlated with the fibrin content of the clot. Both methods are based upon
magnetic actuation and phase-sensitive optical monitoring of nanoscale displacements using
MMOCT, underscoring its utility as a broad-based platform to detect and measure the molecular
structure and composition of blood clots.
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I. Introduction
Blood clotting is the human body’s way of preventing excessive bleeding, while at the same
time, inappropriate clotting at sites of vascular damage is the source of cardiovascular
“events” and the driver of thrombotic complications. The detection of clots and
characterization of clot function is, therefore, of paramount medical importance. Currently,
optical coherence tomography (OCT) is gaining use as an intravascular imaging modality
that provides high-resolution details of vascular lesions, particularly in the coronary artery
for the identification of unstable plaques [1]–[3], assessing vascular conduit quality during
bypass surgery [4], and monitoring balloon inflation during angioplasty [5]. OCT image
contrast is based upon tissue backscattering, which provides only limited information about
vascular structure. New OCT-based methods to specifically contrast blood clots and their
mechanical properties have the potential to greatly expand the clinical utility of OCT.
One of the most advanced techniques for OCT contrast imaging is based upon the use of
magnetic nanoparticles, specifically superparamagnetic iron oxides (SPIOs), that are
magnetically actuated during OCT imaging [6]–[8]. Application of a modulated magnetic
field using external electromagnets causes periodic magnetically induced motion
(magnetomotion) of SPIOs, which is subsequently detected with OCT through a process
dubbed magnetomotive OCT (MMOCT). MMOCT has been employed in a variety of
applications, including in vivo molecular imaging for detection of cancer [9], monitoring
diffusion of SPIOs [8], and tracking SPIO-labeled cells [6]. Because tissue magnetomotion
is dictated by the tissue elastic properties, elastography using MMOCT, or magnetomotive
optical coherence elastography (MMOCE), is also a growing application [10]. In particular,
using MMOCE to measure resonances in the acoustic spectrum of soft tissues has the
potential to be a very accurate method for tissue sample elastometry [11].
For the purposes of contrasting blood clots with MMOCT, combining SPIOs with platelets
is significant because of the capability of these cells to localize to inflamed and injured
vasculature in a wide range of pathologies. The pathophysiological function of platelets is to
detect and adhere to sites of vascular damage for the formation of primary hemostatic plugs,
and then to amplify coagulation reactions so as to limit hemorrhage [12]. As such, SPIO-
labeled platelets have broad-based potential for detection of localized vascular endothelial
defects in cardiovascular disease and trauma.
Rehydrated, lyophilized platelets (RL platelets) are used in this study as an infusion agent
that are prepared from fresh human apheresis platelets and overcome difficulties with
platelet storage and harvesting [13]. Recently, the development of SPIO-RL platelets as a
functional MMOCT imaging agent has been reported [14]. In that study, we found that
SPIO-RL platelets maintained their native hemostatic platelet ability to specifically adhere
to damaged vascular endothelium ex vivo, providing the ability to distinguish between
injured and uninjured endothelium with MMOCT imaging. While the demonstrated
detection sensitivity to SPIO-RL platelets incorporated into blood clots is feasible for in vivo
use; here, we will show how control of SPIO-RL platelet magnetic properties can further
increase imaging sensitivity, which will lower the dose needed in realistic imaging
applications.
At the same time, blood clot elasticity is a potentially powerful metric for predicting the risk
associated with the presence of blood clots. Abnormal clot elasticity is associated with
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myocardial infarction [15], coronary atherothrombosis [16], ischemic stroke [17], venous
thromboembolism [18], and diabetes [19]. The importance of clot elastic modulus is
evidenced by the growing use of devices such as the thromboelastograph (TEG) and the
Hemodyne [20]. As we will show later, MMOCE has the potential to enhance the accuracy
of clot elastometry by the use of resonant acoustics, while using the same imaging hardware
for the detection of SPIO-RL platelets in clots.
II. MMOCT
Here, we briefly review the relevant background and capabilities of MMOCT, for which
detailed theoretical analyses can be found elsewhere [7], [8]. OCT is a favorable platform
for imaging nanoscale tissue displacements such as those induced by SPIOs. OCT is based
upon interferometric detection of backscattered, low-coherence light to optically depth range
tissue structure up to several mean free scattering path lengths deep [21], [22]. Spectral-
domain OCT provides excellent phase (and hence displacement) sensitivity by avoiding the
need for a moving delay line; this is accomplished by collecting the spectral interferogram
and relating it to the time-domain signal through Fourier transformation [23]. While the
phase sensitivity of our OCT system corresponds to a displacement (jitter) noise of ~11 nm,
subnanometer phase sensitivities have been reported [24].
The ability to detect the presence of SPIOs in tissue using OCT and magnetically induced
motion (MMOCT) can be understood in several steps. The application of a gradient
magnetic field B to tissue containing SPIOs results in a local magnetic gradient force F per
volume V according to
(1)
where Mp and Md are the volume magnetizations arising from the SPIOs and the tissue,
respectively. While the magnetization from SPIOs is positive (paramagnetic), the
magnetization from tissue is negative (diamagnetic). As such, the net force between the
paramagnetic and diamagnetic components of the tissue sample can point in either direction.
MMOCT operates by rejecting the negative (diamagnetic) tissue motion to avoid false
positives; therefore, a sufficient concentration of SPIOs is needed to make the force net
positive. Because SPIOs have a magnetic susceptibility >105 times larger than that of tissue,
the net positive force requirement sets the threshold concentration of SPIOs for detection to
be <10−5 fractional volume loading in tissue. Counterintuitively, the use of higher magnetic
fields that saturate the SPIOs act to raise this minimum threshold, because the diamagnetic
components continue to increase linearly [8]. This results in an optimal magnetic field of
typically 0.1–0.2 T, and due to the small imaging volume associated with OCT, only a
small, water-jacketed electromagnet is needed to be placed above the tissue during imaging
(see Fig. 1).
These magnetic gradient forces act collectively on all SPIOs in the tissue volume, resulting
in net body forces inside the tissue that are proportional to the local concentration of SPIOs.
The tissue then elastically deforms in response to mechanical coupling with the SPIOs.
While SPIOs themselves are light absorbing and undetectable, the tissue deformation is
directly detected by OCT. Specifically, the optical phase shift observed in the OCT
interferogram Δφ corresponds to the axial tissue displacement Δz according to Δφ = 4πΔz/
λ. In our MMOCT system, we preferentially induce axial displacements by centering a
solenoid coil on-axis with the imaging beam (see Fig. 1).
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The amount of tissue displacement is both proportional to the concentration of SPIOs and
inversely proportional to the elastic modulus of the tissue; as such, it is not currently
possible to extract a quantitative measurement of one without a priori knowledge of the
other.
The most important feature of MMOCT is the ability to modulate the magnetic gradient
force at a frequency that rejects other sources of noise, particularly tissue movements arising
from respiration and cardiac function. Bandpass filtering of the optical phase signal is
employed around the magnetic modulation frequency, and the addition of a filter based on
the relative phase of the magnetomotion (to reject diamagnetic motion) has resulted in
sensitivities as low as 27 μg/g [8]. This combination of sensitivity, specificity, and speed has
recently enabled a variety of novel studies for tracking SPIOs in vivo [7], [9].
III. MMOCE
Because MMOCT relies on the detection of elastic tissue deformation, it is also possible to
use it in systems with controlled boundary conditions for elastography (MMOCE) [10], [11].
Of special interest is the measurement of small biosamples which can be made to
mechanically resonate at low (<1 kHz) frequencies. Elastometry of such small (<10 cm3),
soft (<100 kPa) biosamples, such as blood clots, is difficult to accomplish by traditional
methods due to large error arising from ambiguity with the actuator contact position, and
due to the need for extremely low actuation forces, low actuator inertia, and nanoscale
displacement sensitivity. MMOCE mediates these difficulties by providing magnetic control
of forces, optical phase detection, and micro- and nanotransducers that are already in contact
with the tissue and impart negligible inertia.
The reason that small, soft biosamples in particular can be made to mechanically resonate is
due to elastic wave reflections from their lower boundary that set up standing longitudinal
waves with wavelengths λn of mode number n as allowed by the boundary conditions. The
resonance frequency ωn associated with each longitudinal mode n can be written generally
as [11]
(2)
where E is the elastic modulus of the tissue, ρ is the mass density, and g is a geometrical
factor that depends only upon n, the boundary conditions, sample geometry, and Poisson’s
ratio. In a previous study [11], it was shown that longitudinal resonances in cylinders with
open sides could be predicted by calculating g according to elastic theory [25]. In this study,
we will focus on the relative changes in E for fibrin clot samples with closed, rectangular
sides by monitoring ω0 and assuming Poisson’s ratio, and therefore g, and λ0, are constant.
In practice, samples with controlled boundary conditions can be obtained by solidifying a
liquid sample (e.g., blood) into a well of defined shape, cutting a solid tissue sample with a
punch as in [26], or by using the OCT system itself to image the shape of the tissue sample.
Another practical simplification we introduce here for clot elastometry (see Fig. 2) is the use
of a microtransducer placed on top of the sample, instead of embedded SPIOs. This avoids
difficulties with the interference that SPIOs have on the clot formation, chemistry, and
mechanical properties.
The nanoscale displacement sensitivity afforded by OCT translates to typically microstrain
sample sensitivity. These perturbative strains allow for measurements of tissue in the linear
viscoelastic regime, where the displacement of the system under time-harmonic excitation,
Oldenburg et al. Page 4













Δz (ω) = Ã (ω) eiωt, can be written in terms of the complex amplitude Ã (ω) as a
Lorentzian:
(3)
where γ is the damping coefficient and q is proportional to the driving force. In our
implementation of MMOCE, a chirped (frequency-swept) sinusoidal magnetic force is
applied to measure the acoustic spectrum of a tissue sample. Chirping provides a
measurement of the system impulse response and has a signal-to-noise advantage over the
use of a mechanical impulse because the measurement is spread out over a longer
acquisition time. It is important to note that we previously found that tissues tend to be
underdamped [11], with a quality factor Q ≈ 3 for rat liver, such that the amplitude of
magnetomotion at the acoustic resonance is significantly amplified.
IV. Methods
A. Preparation of SPIO-RL Platelets in Clot-Like Aggregates
Here, we describe the preparation of SPIO-RL platelet aggregates for a comparative study
with the dispersed SPIO-RL platelets in our previous study [14]. In this study, dextran-
coated SPIOs were prepared with the method of Molday and MacKenzie [27] at an iron
concentration of 0.91 mg/ml in citrated saline (5.375 mM citrate, 165 mM NaCl, pH = 7.4).
This method is expected to produce dextran-coated SPIOs with core sizes of 10–20 nm,
outer diameter of 30–40 nm, and 50% Fe content by weight. In comparison, in our previous
study Feridex I.V. (Advanced Magnetics) was used which is also a dextran-coated SPIO
with core size ~5 nm, number-weighted hydrodynamic diameter of 36 nm [28], and ~60%
Fe content by weight (computed from the concentrations reported on the package insert).
SPIO-RL platelets were prepared by incubating an equal volume of prepared SPIOs with
one-day-old apheresis platelets at a concentration of 1.1 × 109/cm3. SPIO platelet aggregates
were then separated from single platelets with internalized SPIO and free extracellular SPIO
with differential sedimentation velocity and density gradient centrifugation as described
elsewhere [29] and then subjected to aldehyde stabilization and lyophilization [13].
Examination with light microscopy showed that after rehydration, the SPIO-RL platelets
were present as aggregates with a structure typical of primary hemostatic clots.
The main difference between the preparation used here compared to that reported earlier
[14] involves how the platelets were separated from excess SPIO. Size exclusion
chromatography was utilized to separate platelets from extracellular SPIO in the earlier
study. This produced SPIO-containing platelets with an activated nondiscoidal morphology
with extended pseudopodia, but that were largely unaggregated. In contrast, when excess
SPIO was separated from platelets on the bases of sedimentation velocity and density with
centrifugation, an aggregated population of platelets with activation and associative
properties similar to platelets in primary hemostatic clots was obtained. The platelets were
present in aggregates of ten to several hundred with closely juxtaposing membranes, showed
signs of cytoskeletal rearrangement, and granule secretion. These results demonstrate that
care will be required to prepare infusible SPIO-RL platelets for potential human
applications.
B. Preparation of Fibrin Clots
Simulated clots composed of fibrin were prepared to investigate the relationship between
fibrin content and clot elasticity. Fibrin clots were made by mixing 0.3–3.7 mg/mL (final
concentration) plasminogen-, fibronectin-, and von Willebrand factor-depleted human
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fibrinogen (Enzyme Research Laboratories, South Bend, IN) with 25 nM (final
concentration) human thrombin (Haematologic Technologies, Essex Junction, VT) in 20
mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (pH 7.4), 150 mM NaCl, 1 mg/
mL bovine serum albumin, and 5 mM CaCl2 at room temperature. Clots were formed inside
custom-printed rectangular wells of 6 mm × 6 mm × 10 mm (length × width × depth)
dimensions in a humidified chamber, and MMOCE was performed after fibrin clots had
fully formed (~60 min).
C. Magnetic Properties: Measurements and Modeling
We employed superconducting quantum interference device (SQUID) magnetometry to
measure the magnetic properties of SPIOs and SPIO-RL platelet aggregates. A 5 T SQUID
magnetometer (Quantum Design) was employed for this study. SPIOs (at 22.5 μg Fe/mL)
and SPIO-RL platelets (at 65 μg Fe/mL) were dispersed into 1% agarose and sealed in a
plastic capsule for analysis. In addition, SPIO-RL platelets were analyzed in anticoagulated
fresh porcine blood, and in clotted porcine blood (by addition of 11 mM CaCl2), both at a
concentration of 41–43 μg Fe/mL. Porcine blood was drawn from healthy swine according
to approved protocols of the Institutional Animal Care and Use Committee at the University
of North Carolina at Chapel Hill. Magnetization versus field M (H) hysteresis loops were
measured at 20 °C. Calibration and subtraction of the diamagnetic contribution from the
agarose, blood, and plastic capsule was performed as described previously [14]. Then, the
saturation magnetization Ms and an effective magnetic moment μ were used as free-fitting
parameters in the Langevin function given by
(4)
where kB is Boltzmann’s constant, T is the temperature, and the effective moment μ can be
expressed in numbers of Bohr magnetons μB. We note that μ can be interpreted as the
effective size of the superparamagnetic spin cluster and is proportional to χ/Ms and thus
independent of the amount of material (either mass or volume) in the sample, where χ is the
low-field magnetic susceptibility. As such, μ is an important parameter that determines the
low-field susceptibility and magnetization, and consequently the magnetically induced force
(1), at low fields like those used in MMOCT.
In order to further examine the magnetic interactions and the effective moment of SPIOs and
SPIO-RL platelets, temperature-dependent field-cooled (FC) and zero-field-cooled (ZFC) dc
magnetization and ac susceptibility measurements were performed. The ZFC measurement
entailed first cooling to 5 K in nominal zero field (<1 Oe), applying a 50-Oe field, and then
measuring the dc and ac magnetic responses as the temperature was warmed to 320 K. The
FC scan was subsequently performed in 50 Oe as the temperature was cooled from 320 back
to 5 K. AC susceptibility was performed with a field modulation frequency of 10 Hz and
amplitude of 4 Oe. At temperatures above the onset of irreversibility, the measured low-field
magnetization and susceptibility were, respectively, fit to the Curie law according to
(5)
Here, the value for Ms from field-dependent measurements was used, and the effective
moment μ was the only fitting parameter.
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D. Methods for MMOCT and MMOCE
The MMOCT methods used for detection and imaging of SPIO-RL platelet aggregates in
tissue phantoms are identical to those described in detail previously [14]. Briefly, a custom
spectral-domain OCT system comprised of a Ti:Sapphire laser source centered at 810 nm
with ~125-nm bandwidth (Griffin, Kapteyn-Murnane Labs, Boulder, CO) and use of a 30-
mm focal length imaging lens provided 3 × 12 μm (axial × transverse) imaging resolution
and ~10 mW of optical power at the sample. Images were collected into successive B-mode
(x–z) frames over 2500 × 9 × 1024 pixels (x × y × z) at a linerate of 1 kHz with a charge-
coupled device camera (Dalsa Piranha 2) during magnetic field modulation at 100 Hz. The
peak magnetic field and gradient were 0.15 T and 15 T/m, respectively. Reconstruction of
OCT and MMOCT images was performed according to a phase-resolved method described
previously using bandpass filtering and removal of induced motions from the diamagnetic
tissue background [8].
MMOCE was performed using the same system hardware for elastometry of fibrin clots.
General methods for MMOCE using resonant acoustic spectroscopy have been described in
detail previously [11]. The primary difference between this and previous work is our use of
a microtransducer placed onto the top surface of the clot, instead of embedding clots with
SPIOs. However, care is needed to avoid the unwanted perturbation of the system inertia by
the use of a microtransducer with mass much smaller than that of the sample. In our
experiments, the microtransducer consisted of a 2 mm × 2 mm × 0.025 mm amorphous steel
alloy sheet wrapped with tape to provide diffuse optical scattering; its mass was ~2 mg,
which is less than 1% of our sample mass of 360 mg.
Experiments were performed by tracking the axial displacement of the microtransducer with
the OCT system in M-mode (depth at one transverse position versus time) at a linerate of 2
kHz, while sweeping the magnetic field modulation rate from 0 to 400 Hz. In these
experiments, the solenoid was placed beneath the sample to provide a downward force onto
the micro-transducer. Furthermore, the voltage was decreased to prevent motion that would
be too rapid for detection by the OCT system (avoiding phase wrapping during the period of
line acquisition); the resulting magnetic field was, therefore, much smaller than 0.15 T. M-
mode images were collected into 4000 × 1024 pixels (time × depth). Image processing was
performed to extract the amplitude and phase of the acoustic spectrum by dividing the
optical phase data by the chirped waveform of the magnetic force, as described in detail
previously [11]. The position of the fundamental resonant frequency was obtained by
separately fitting the amplitude (absolute value) and phase (argument) of the displacement
spectrum of (3), with ω0 and γ as fitting parameters, and computing the average value of
ω0. Two scans were obtained for each sample.
V. Results and Discussion
A. Ex Vivo Imaging of Blood Clots Using MMOCT and SPIO-RL Platelets in Porcine Arteries
In this section, we briefly review our previous results using SPIO-RL platelets to provide
specific imaging contrast to damaged vascular endothelium. This will be a point of
comparison for the new SPIO-RL platelets analyzed in this study. We found that each
platelet could be loaded with 48.3 ± 0.6 fg Fe (by mass spectrometry) from SPIOs
comprised of Feridex I.V. The SPIOs in each SPIO-RL platelet, then, act as a magnetic
handle by which to contrast the platelets. At these loading levels, we found that the magnetic
properties of SPIO-RL platelets predict a threshold concentration of 0.27 × 109 /cm3 for
MMOCT contrast, and that, in practice, SPIO-RL platelets were detected at concentrations
≥1.5 × 109 /cm3. Assuming an average platelet volume of 10.6 fL [30], this latter
corresponds to a volume fraction of only 1.6%. In comparison, microscopic examination of
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arterial thrombi reveals that native platelets can occupy a significant fraction of the
thrombus [31].
Our most important finding is that SPIO-RL platelets maintained their native platelet ability
to specifically adhere to injured arteries, thus acting as contrast agents for MMOCT-based
detection of blood clots [14]. Briefly, ex vivo porcine arteries were injured with a sharp steel
cytology brush and ligated at one end with a catheter for sample infusion. A mixture of
normal porcine blood containing the endogenous porcine platelets and SPIO-RL platelets
was infused over a 4-min period at 0.25 mL blood mixture/min. After exposure, arteries
were saline flushed and images were obtained before and after opening the arteries. One out
of two artery segments showed significantly large MMOCT signal, with an image-averaged
signal exceeding 3.2 dB, compared to ≤0.12 dB for control.
Fig. 3 displays a representative set of MMOCT images for damaged and undamaged
arteries. Note that no MMOCT signal is obtained in the absence of magnetic field
modulation, as expected. Importantly, no significant MMOCT signal is obtained in a control
(undamaged) blood vessel that was exposed to the same concentration of SPIO-RL platelets.
This suggests that platelets, after preparation into SPIO-RL platelets, retained the ability to
distinguish injured from uninjured endothelium. This is consistent with earlier evidence that
the hemostatic function of RL platelets is mediated by activatable primary hemostatic
mechanisms in combination with activation of the cell membrane to catalyze coagulation
cascade turnover [32]. Future study of SPIO-RL platelets is needed to determine whether the
introduction of SPIOs modify these hemostatic mechanisms.
B. Improved Magnetic Properties of SPIO-RL Platelets Lead to Higher Sensitivity in
MMOCT
While the previous results for blood clot detection by MMOCT of SPIO-RL platelets are
promising, further reduction of the detection threshold would relax the practical requirement
upon the dose of SPIO-RL platelets needed for blood clot detection. This can be
accomplished by improving the magnetic properties of the SPIO-RL platelets. In this study,
SPIO-RL platelet aggregates were prepared which contained >4× the amount of Fe per
platelet (see Table I). Furthermore, their activation and hemostatic clot-like formation may
approximate the in vivo environment of SPIO-RL platelets that have adhered to a blood clot.
As such, we measured and compared the magnetic and MMOCT contrast properties of the
SPIO-RL platelet aggregates to the previous SPIO-RL platelets, which are summarized in
Table I.
It is important to note which magnetic properties are most effective for enhancing MMOCT
contrast. According to (1), the magnetically induced force is dictated by the difference in
magnetization of the SPIOs from that of the diamagnetic medium around the SPIOs. As
shown previously [8], this actually dictates the use of smaller magnetic fields (typically 0.1–
0.2 T) that do not fully saturate the SPIOs, in order to minimize the deleterious effects of the
diamagnetic medium and to optimize the MMOCT detection threshold. The ideal SPIO-RL
platelet, then, is one that provides the greatest magnetization at fields below saturation.
Functionally, this figure of merit is improved by either increasing the total amount of Fe
inside each platelet or increasing the effective size of each superparamagnetic spin cluster,
i.e., effective moment μ. As we show below, the SPIO-RL platelets aggregates in this study
display improvements in both of these.
As described in (4), this effective superparamagnetic spin cluster μ directly affects the
susceptibility and thus the initial slope of the magnetization at low field, as shown in Fig. 4,
where example field-dependent magnetization curves for free SPIOs and SPIO-RL platelets
are plotted. The SPIO-RL platelets in this study are found to display an effective spin cluster
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>3× larger than free SPIOs (see Table I); accordingly, the initial slope of these samples is
much larger (~3–4 times) than that for free SPIOs (see Fig. 4). While Ms is proportional to
the total mass of Fe, the normalized low-field slope and μ are independent of the Fe loading
of the SPIO-RL platelets.
As a separate measurement of μ, temperature-dependent magnetization and susceptibility at
low applied fields were obtained and fit to the Curie law in (5) (see Fig. 5). Because these
fields (50-Oe dc field and 4-Oe ac modulations) are lower than those used in the field-
dependent scans, the values obtained are expected to be very close to the zero-field value of
μ. As seen in Table I, μ from the temperature-dependent (low-field) scans are higher than
that from the field-dependent (high-field) scans, but show the same relative enhancement for
that of SPIO-RL platelets compared to that of the free SPIOs.
The enhancement in μ for the SPIO-RL platelet aggregates from free SPIOs was not
observed for the SPIO-RL platelets in our previous study with Feridex I.V., where the values
for μ are the same for both and only slightly larger than that of the prepared, free SPIOs in
this study. Interestingly, this apparent increase in the effective magnetic cluster size for the
SPIO-RL platelet aggregates is associated with a larger Fe loading, as well as an aggregated,
clot-like nature. This suggests that magnetic interactions between SPIO particles are
becoming significant, similar to other reports in tightly packed SPIO systems [33].
In addition, the characteristic temperatures, e.g., blocking temperature, associated with low-
temperature superparamagnetic behavior also exhibit corresponding large enhancements, as
shown in Fig 5. The measured dc magnetization exhibits FC and ZFC irreversibility with a
characteristic ZFC maximum below the onset of irreversibility [see Fig. 5(a)]. Both the
irreversibility temperature and the ZFC maximum temperature show enhancements for the
SPIO-RL platelet aggregates with respect to the free SPIOs. At temperatures above the onset
of irreversibility, the samples are superparamagnetic, as both the dc behavior and the real
part of ac susceptibility (in-phase component) obey the Curie law (5) [lines in Fig. 5(a) and
(b)]. From the Curie law fits, the low-field values for μ were obtained (see Table I). At
lower temperatures, the real part of the ac susceptibility (in-phase component) exhibits a
maximum, which corresponds to the blocking temperature at the measurement frequency.
The respective blocking temperatures for the SPIO-RL platelet aggregates and the free
SPIOs are 150 ± 5 K and 50 ± 5 K. The latter is consistent with the literature value of ~60 K
for ferumoxides [34]. Below the blocking temperature, dissipation processes become
significant as the imaginary part (out-of-phase component) of susceptibility becomes
appreciable.
While the peaks in the ac susceptibility (both real and imaginary parts in Fig. 5(b) and (c),
respectively) for the SPIO-RL platelet aggregates shift to higher temperatures from those of
the free SPIOs, the normalized peak heights are nearly identical between the two types of
samples. This observation indicates that, other than having a different effective size of
superparamagnetic spins, interactions between them are “free SPIO-like,” i.e., negligible.
One possible scenario emerges, such that within the platelet aggregates, 3–4 SPIO particles
form tightly packed clusters with sufficiently strong interparticle magnetic interactions to
couple their spins together, leading to a larger effective superparamagnetic spin. The nature
of the small-packed clusters and the mechanism for their formation are presently unknown;
elucidating these would require further investigations.
In order to relate these magnetic property measurements to MMOCT contrast, MMOCT was
performed on free SPIOs and SPIO-RL platelet aggregates dispersed in 1% agarose with
0.5–2 mg/g TiO2 micropowder as an optical scatterer. The measured magnetic properties of
each sample were used to predict the induced magnetization at the peak modulation
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magnetic field of 0.15 T used during MMOCT (see Table I), while accounting for the
negative magnetization from the diamagnetic background. In order to compare these
samples with those measured previously, the Fe concentration was held constant at 67 μg/
mL.
As expected, the predicted magnetization for each sample is strongly correlated with the
resulting MMOCT contrast in tissue phantoms (see Table I). Representative MMOCT
images of prepared SPIOs and SPIO-RL platelet aggregates are displayed in Fig. 6. The
highest contrast at 67 μg/mL was obtained for the SPIO-RL platelet aggregates, averaging
4.5 ± 0.4 dB. Importantly, the platelet number density this corresponds to is only 0.31 ×
109 /cm3, or over 4 × less than the previous SPIO-RL platelets.
These results suggest that the improved MMOCT contrast properties of SPIO-RL platelet
aggregates are both a function of the improved Fe loading, and of particle-particle magnetic
interactions, which improve their magnetic properties at the fields used in MMOCT
imaging. Future study is needed to determine whether the aggregation of the platelets into a
clot-like formation causes some of these improved properties, which may be a new
mechanism of enhancing contrast in vivo that is activated when SPIO-RL platelets adhere to
clots.
C. MMOCE of Simulated Clots is Related to Fibrin Content
As a proof of principle, we show how the use of magnetic forces and OCT may also be used
to assess the stiffness of clots. Here, we use purified fibrin clots produced with varying
amounts of fibrinogen, which is an important component of both arterial and venous
thrombi. Fibrin network properties (viscoelasticity, permeability, and resistance to lysis)
have been correlated with bleeding and clotting disorders [35]. Furthermore, fibrin network
structure (branch point and fiber densities) is known to significantly influence the clot elastic
modulus [36], [37].
Using MMOCE, we measured the acoustic spectrum of fibrin clots polymerized into open-
faced rectangular wells. Similar to previous work with agarose phantoms [11], we found that
the fundamental resonance frequency, f0 = ω0 /2π, could be measured by fitting the spectra
of the mechanical amplitude and phase lag (the absolute value and argument of Ã(ω),
respectively), to (3). A representative example is shown in Fig. 7. In this example, the
fundamental mode near 105 Hz is slightly overlapped by a higher frequency mode near 175
Hz, which reduces the goodness of fit at frequencies above the fundamental mode. In
particular, the phase lag shifts from 0 (in-phase motion) to π (out-of-phase motion) as the
frequency is swept past the resonance. Because the phase spectrum shows the phase
lowering again immediately after reaching π above f0, it is indicative of a second
mechanical mode being excited near 175 Hz. Also, noise peaks are evident at 60 Hz and its
harmonics. Despite these difficulties, it was possible to fit both curves to a consistent value
of f0 (103.7 Hz for the amplitude and 106.7 Hz for the phase). Furthermore, the fibrin clot
system appears to be underdamped, with a quality factor Q ≈ 4.
We found that the fundamental-mode frequency for fibrin clots was highly correlated with
fibrinogen content (see Fig. 8). Because the clots are all polymerized into wells with the
same dimensions and boundary conditions, we know that the elastic modulus E is
proportional to  according to (2). Therefore, the apparent 4.7 × increase in f0 from 0.3 to
3.7 mg/mL is indicative of a 22 × increase in the clot elastic modulus. This finding is similar
to previous fibrin-dependent measurements of the clot elastic modulus [37]. However,
unlike previous techniques, this method has the advantage of being a resonance method that
has the potential for high accuracy. The high displacement sensitivity of the OCT system
provides typically microstrain sensitivity, permitting the evaluation of the clot elastic
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modulus under perturbative strain conditions where the behavior is linear, reversible, and
easy to model. Furthermore, the use of the same MMOCT/MMOCE system hardware for
both clot imaging and elastometry can lead to new associations between clot structure and
function.
VI. CONCLUSION
Our findings show how MMOCT/MMOCE can be used as a platform for both imaging and
elastometry of blood clots. Evidence of particle–particle magnetic interactions suggests that
SPIOs inside RL platelets under aggregated conditions, such as those found in a blood clot,
can provide enhanced contrast properties for MMOCT and lower the threshold for detection
to a clot loading of 3.1 × 108 platelets/cm3. At the same time, MMOCE reveals the strong
fibrinogen dependence of clot elastic modulus. As it stands, this MMOCT/MMOCE
platform has uses for fundamental studies of blood clot formation dynamics, and may
uniquely be used to connect clot viscoelastic properties with platelet activity, and to assess
the efficacy of RL platelets as a hemostatic therapy.
Future work may lead to methods for the in vivo detection and assessment of clot elastic
modulus by using SPIO-RL platelets as both the imaging agent, and as the transducer for
acquiring the acoustic spectrum of the clot. This will pose several challenges. The arbitrary
shape of blood clots will require imaging of clot boundary conditions and subsequent
construction of finite element models to associate acoustic vibrations with mechanical
properties. The physiological motion of the blood vessel due to cardiac function will need to
be rejected, possibly by bandpass filtering as performed for MMOCT imaging in [8], or by
appropriate synchronization of the chirped scan with the cardiac cycle. In the long term, an
intravascular MMOCT/MMOCE system may be envisioned in which magnetic gradient
fields are delivered from outside the patient while employing a standard OCT catheter for
imaging. In the more immediate future, in vivo imaging of superficial vessels in animal
models of vascular damage will guide the design of an intravascular imaging system.
By leveraging the ability for SPIO-RL platelets to target blood clots, we may envision an
MMOCT/MMOCE device that can both detect early stage thrombosis and assess its relative
risk to the patient by viscoelastic property measurement. Fundamentally, the ability to image
nanoscale displacements induced by magnetic manipulation of SPIOs in tissue and loaded
into cells will lead to many new biophysical discoveries.
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Cartoon schematic of the principle of MMOCT depicting how a magnetic actuation of
nanoparticles inside the imaging volume induces a phase shift in the OCT interferogram.
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Cartoon schematic of MMOCE depicting the geometry of clot elastometry performed in a
rectangular microwell.
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OCT (red) and MMOCT (green) of ex vivo porcine arteries exposed to SPIO-RL platelets in
a flow chamber. MMOCT contrast is specific to the artery that was injured, due to specific
adhesion of SPIO-RL platelets. Lower right inset: TEM of an SPIO-RL platelet, 1 μm
scalebar.
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Representative magnetization M versus applied magnetic field H data for freely dispersed
SPIOs and SPIO-RL platelet aggregates at 20 °C, with best-fit line according to (4).
Magnetization is normalized by the saturation magnetization Ms for each sample. The
apparent systematic difference between theory and experiment is possibly due to size
polydispersity of the SPIOs resulting in a distribution of μ values. The dashed lines are
extensions of the low-field slopes as a visual guide.
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Temperature-dependent FC and ZFC magnetometry of SPIOs and SPIO-RL platelet
aggregates, with a Curie law fit according to (5). The magnetization M is normalized by the
saturation magnetization Ms for each sample. (a) DC magnetometry at 50 Oe; (b) and (c)
real and imaginary parts, respectively, of the ac magnetic susceptibility (χA C) at 10 Hz and
4 Oe.
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OCT (red) and MMOCT (green) of agarose tissue phantoms containing free SPIOs and
SPIO-RL platelet aggregates at 67 μg Fe/mL. While a small amount of signal is observed
for free SPIO, MMOCT contrast is significantly enhanced in the aggregated platelets.
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Acoustic spectral amplitude and phase lag of a fibrin clot made with 5 mg/mL fibrinogen
showing a fundamental resonance mode near 105 Hz, and a second mode near 175 Hz. Best
fit curves are plotted in red for the fundamental mode according to (3).
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Plot of the resonant frequency of the longitudinal mode in fibrin clots as a function of the
fibrinogen concentration. Elastic modulus is proportional to the square of the resonant
frequency.
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